Literature DB >> 20508243

Olanzapine for nausea and vomiting.

Nerissa Licup1.   

Abstract

Nausea and vomiting are often encountered in palliative care patients. Multiple medications are available to provide relief. However, several drug combinations are usually used to treat emesis. Current research has identified several receptors that trigger nausea and vomiting, hence the difficulty of using only 1 medication to provide relief. Olanzapine is a drug approved for treatment of schizophrenia and mania. It blocks multiple neurotransmitters dopaminergic, serotonergic, adrenergic (alpha(1)), histaminergic, and muscarinic receptors. Most of these receptors are also involved in causing emesis. Studies have shown that olanzapine could be used to treat nausea and vomiting with promising results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508243     DOI: 10.1177/1049909110369532

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  8 in total

Review 1.  Nausea and Vomiting in Advanced Cancer.

Authors:  Rudolph M Navari
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

2.  Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.

Authors:  Carlo Pirri; Evan Bayliss; James Trotter; Ian N Olver; Paul Katris; Peter Drummond; Robert Bennett
Journal:  Support Care Cancer       Date:  2012-09-14       Impact factor: 3.603

Review 3.  [Chemotherapy-induced nausea and vomiting : Current recommendations for prophylaxis].

Authors:  E Storz; J E Gschwend; M Retz
Journal:  Urologe A       Date:  2018-05       Impact factor: 0.639

Review 4.  Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

Authors:  Martino Belvederi Murri; Argentina Guaglianone; Michele Bugliani; Pietro Calcagno; Matteo Respino; Gianluca Serafini; Marco Innamorati; Maurizio Pompili; Mario Amore
Journal:  Drugs R D       Date:  2015-03

5.  Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association.

Authors:  Siddharth Sarkar; Nitin Gupta
Journal:  BJPsych Bull       Date:  2017-08

6.  The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature.

Authors:  G Saudemont; C Prod'Homme; A Da Silva; S Villet; M Reich; N Penel; V Gamblin
Journal:  BMC Palliat Care       Date:  2020-04-22       Impact factor: 3.234

7.  Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial.

Authors:  Rudolph M Navari; Cameron M Pywell; Jennifer G Le-Rademacher; Patrick White; Andrew B Dodge; Costantine Albany; Charles L Loprinzi
Journal:  JAMA Oncol       Date:  2020-06-01       Impact factor: 31.777

8.  A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting.

Authors:  Xiao-fei Wang; Yun Feng; Ying Chen; Bei Li Gao; Bao-hui Han
Journal:  Sci Rep       Date:  2014-04-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.